Bone, soft tissue and other sarcomas
The following list provides a brief description of bone, soft tissue and other sarcoma trials that are recruiting participants in Western Australia. If you would like more information please follow the links provided, contact one of the trial sites or speak with your doctor.
Please note that this list is based on information provided to the Cancer Council by WA hospitals and may not include all clinical trials that are running in WA.
Where ‘N/A' appears - this means the lacking information has not been provided to date to the Cancer Council.
MoST Addendum 5
| Registered Title | Single arm, open label, signal seeking, phase IIa trial of the activity of eribulin in patients with advanced CD31 positive angiosarcoma and selected CD31 positive sarcomas. |
| Purpose | This is a substudy of the Cancer Molecular Screening and Therapeutics (MoST) Program, which is registered on ANZCTR with ID ACTRN12616000908437. The purpose of this is to investigate whether gene or CD31 protein profiles may be used to select the best treatment for participants with advanced cancer. |
| Lay Summary | N/A |
| WA Trial Sites |  Linear Clinical Research Ph. 08 6382 5513 |
| Links | Australian New Zealand Clinical Trial Registry |
Acknowledgments: Australian New Zealand Clinical Trial Registry
rEECur
| Registered Title | International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma |
| Purpose | The purpose of this study is to determine which of the most commonly used chemotherapy used in recurrent and primary refractory Ewing's Sarcoma is most beneficial. |
| Lay Summary | N/A |
| WA Trial Sites |  Medical Oncology Ph. (08) 6383 3000 |
| Links | Australian New Zealand Clinical Trial Registry |
Acknowledgments: Australian New Zealand Clinical Trial Registry
